Bowhead Specialty Holdings Inc.

What they do

Bowhead offers commercial specialty property and casualty insurance to businesses of varying size, industry and complexity, focusing on casualty, professional liability and healthcare liability risks. Products are delivered through two underwriting models: a craft model for large, complex, higher-severity risks and a digital model including Baleen Specialty and express small-business offerings. Policies are primarily written on a non-admitted, or excess and surplus lines, basis and issued on AmFam paper through its wholly-owned MGA subsidiary BSUI, with risk reinsured 100% to its wholly-owned insurer BICI.

Revenue drivers

• Casualty — Provides tailored primary and excess general liability coverage, including environmental contractor and site pollution liability, through a wholesale-only distribution channel for construction, distribution, manufacturing, real estate, public entity and hospitality risks. Delivered through the craft underwriting model; the filing does not break out division-level revenue.
• Professional Liability — Writes admitted and E&S coverage for standard and nonstandard risks across a broad variety of entities, including publicly traded companies. The filing does not disclose this division's revenue contribution.
• Healthcare Liability — One of four underwriting divisions named in the 10-K, alongside Casualty, Professional Liability and Baleen Specialty. Division-level revenue is not disclosed in the excerpts provided.
• Baleen Specialty and express — Digital model targeting small, distressed or hard-to-place risks with more restrictive coverage, plus express offerings that simplify submission, underwriting and servicing for small and mid-sized accounts. No revenue figures are provided in the source excerpts.

Recent performance

Total revenue rose from $187.6M in 2022 to $283.4M in 2023, $425.7M in 2024 and $551.6M in 2025. Net income increased from $11.3M in 2022 to $25.0M in 2023, $38.2M in 2024 and $53.8M in 2025, with diluted EPS of $0.47, $1.04, $1.29 and $1.59 respectively. Operating cash flow grew from $181.6M in 2022 to $236.2M in 2023, $294.3M in 2024 and $331.6M in 2025. Quarterly revenue was $143.9M in Q3 2025, $151.7M in Q4 2025, $155.7M in Q1 2026 and $163.9M in Q2 2026. At June 30, 2026, total assets were $2.68B, total liabilities $2.21B, shareholder equity $472.4M, cash and equivalents $141.7M and long-term debt $146.6M.

Strategy

Bowhead's stated objective is to generate consistent underwriting profits across product offerings and through all market cycles while prudently managing capital. It operates through a craft model for large, complex, higher-severity risks and a digital model, including Baleen Specialty and express small-business offerings, for smaller, simpler, scalable business. Policies are written on a non-admitted E&S basis to allow rapid adjustment to market opportunities, and distributed through selected wholesale and retail partners. The AmFam relationship lets Bowhead issue on AmFam paper via BSUI in exchange for a ceding fee, with risk fully reinsured to BICI, enabling efficient capital deployment. The company describes itself as a nimble, remote-friendly organization seeking best-in-class underwriting talent nationwide.

Risks

• Underwriting risk assessment — The 10-K states financial condition and results could be materially adversely affected if the company does not accurately assess its underwriting risk.
• AmFam relationship — Inability to maintain the strategic relationship with AmFam would materially adversely affect the business, and a decline in AmFam's financial strength rating or financial size category may adversely affect results.
• Distribution concentration — The business depends on insurance retail agents, brokers and wholesalers and relies on a select group of brokers whose relationships may not continue.
• Reserve adequacy and reinsurance — Loss and loss expense reserves may be inadequate to cover actual losses, and the company may be unable to purchase third-party reinsurance in desired amounts on commercially acceptable terms.

Outlook

The source material does not provide quantified forward guidance or specific targets. The 10-K and 10-Q describe management's objective of consistent underwriting profits across product offerings and through all market cycles while prudently managing capital. The 10-Q discloses a proposed acquisition of Bowhead by AmFam, with completion subject to conditions including stockholder approvals and regulatory clearances, and notes related risks and uncertainties. No management outlook figures for revenue, earnings or combined ratio are provided in the excerpts.